Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.
about
Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to HeparinEnhancing angiogenesis alleviates hypoxia and improves engraftment of enteric cells in polycaprolactone scaffoldsHeparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.Novel Heparin Receptor Transmembrane Protein 184a Regulates Angiogenesis in the Adult Zebrafish Caudal Fin.Heparin responses in vascular smooth muscle cells involve cGMP-dependent protein kinase (PKG)
P2860
Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@en
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@nl
type
label
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@en
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@nl
prefLabel
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@en
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@nl
P2093
P2860
P356
P1476
Heparin treatment of vascular ...... specificity phosphatase MKP-1.
@en
P2093
Albert C Gilotti
Cheryl Isleib Blaukovitch
Daniela Kanyi
Linda J Lowe-Krentz
Raymond Pugh
P2860
P304
P356
10.1002/JCB.22543
P577
2010-05-01T00:00:00Z